圣达生物：使用闲置募集资金5000万元进行现金管理

Core Viewpoint - The company, Shengda Biology, announced the use of idle raised funds for cash management, indicating a strategic move to enhance liquidity and yield on its financial resources [1] Group 1: Financial Management - Shengda Biology and its subsidiaries will utilize up to RMB 23,000.00 million of temporarily idle raised funds for cash management [1] - The total amount for this cash management initiative is RMB 5,000.00 million, which will be invested in structured deposit products from the Bank of China [1] - The expected annualized yield for the investment ranges from 0.60% to 1.80%, with a product duration of 32 days [1]